|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/2803 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 16/2809 | (2013.01) | ||
| A61K 35/17 | (2015.01) | ||
| C07K 16/2818 | (2013.01) | ||
| C12N 5/0783 | (2010.01) | ||
| C07K 16/2863 | (2013.01) | ||
| C07K 16/2878 | (2013.01) | ||
| C07K 16/24 | (2006.01) | ||
| C07K 16/30 | (2006.01) | ||
| C07K 16/30 | (2013.01) | ||
| C07K 16/32 | (2006.01) | ||
| C07K 16/32 | (2013.01) | ||
| C07K 16/40 | (2006.01) | ||
| C07K 16/40 | (2013.01) | ||
| C07K 16/4241 | (2013.01) | ||
| C07K 16/42 | (2006.01) | ||
| C07K2317/21 | (2013.01) | ||
| C07K2317/31 | (2013.01) | ||
| C07K2317/34 | (2013.01) | ||
| C07K2317/622 | (2013.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K2317/732 | (2013.01) | ||
| C07K2317/74 | (2013.01) | ||
| C07K2317/75 | (2013.01) | ||
| C07K2317/92 | (2013.01) |
| (11) | Number of the document | 4269445 |
| (13) | Kind of document | T |
| (96) | European patent application number | 23187272.2 |
| Date of filing the European patent application | 2021-08-14 | |
| (97) | Date of publication of the European application | 2023-11-01 |
| (45) | Date of publication and mention of the grant of the patent | 2024-06-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| PCT/GB2020/051959 | 2020-08-14 | WO | |
| 202102222 | 2021-02-17 | GB | |
| 202102224 | 2021-02-17 | GB |
| (72) |
UDEN, Mark , GB
TUNA, Mihriban , GB
MOUNT, Natalie , GB
GOOD, Robert , GB
FREEDMAN, Joshua , GB
BHUMBRA, Shefali , GB
NUSSBAUMER, Oliver , GB
MEHTA, Raj Jaysukhlal , GB
|
| (73) |
GammaDelta Therapeutics Limited ,
WestWorks
195 Wood Lane
White City Place, London W12 7FQ,
GB
|
| (54) | MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES |
| MULTISPECIFIC ANTI-TCR DELTA VARIABLE 1 ANTIBODIES |